Cipla Limited: NCLT Order for Amalgamation/Merger Received

M&A / JV 19 Aug 2026 · Filed / open· ✓ Verified

Cipla Limited filed a notice with the National Stock Exchange on 19 August 2026 confirming receipt of an order from the Hon'ble NCLT, Mumbai Bench, granting approval for an amalgamation or merger. The tribunal order is the critical gating approval under Section 230–232 of the Companies Act, 2013, permitting the scheme to proceed to implementation. The NSE notification serves as the formal market intimation and triggers disclosure obligations. The specific parties to the merger, merger ratio, and effective date are not disclosed in the NSE intimation alone and require review of the tribunal order and the scheme of amalgamation filed with the tribunal.

Why it mattersNCLT approval of a Cipla merger/amalgamation establishes the legal foundation for scheme implementation; the tribunal's approval removes the primary regulatory gate for cross-border or domestic pharma consolidation under the Companies Act, enabling subsequent share-swap execution and regulatory filing with MCA.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals